Pharmacokinetic evaluation of two pirfenidone formulations in patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease characterized by an abnormal activation of lung epithelium and fibroblasts, as well as an excessive accumulation of extracellular matrix. Pirfenidone was introduced as a therapeutic option for IPF and chronic hypersensitive pneum...

Descripción completa

Detalles Bibliográficos
Autores principales: Barranco-Garduño, Lina Marcela, Buendía-Roldan, Ivette, Rodriguez, Juan Jose, González-Ramírez, Rodrigo, Cervantes-Nevárez, Ariadna N., Neri-Salvador, Juan Carlos, Carrasco-Portugal, Miriam del Carmen, Castañeda-Hernández, Gilberto, Martinez-Espinosa, Karen, Selman, Moisés, Flores-Murrieta, Francisco Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610245/
https://www.ncbi.nlm.nih.gov/pubmed/33163646
http://dx.doi.org/10.1016/j.heliyon.2020.e05279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610245/
https://www.ncbi.nlm.nih.gov/pubmed/33163646
http://dx.doi.org/10.1016/j.heliyon.2020.e05279

Ejemplares similares